4.8 Article

Viral GPCR US28 can signal in response to chemokine agonists of nearly unlimited structural degeneracy

期刊

ELIFE
卷 7, 期 -, 页码 -

出版社

ELIFE SCIENCES PUBLICATIONS LTD
DOI: 10.7554/eLife.35850

关键词

-

类别

资金

  1. National Institutes of Health [R01 AI125320]
  2. Howard Hughes Medical Institute
  3. American Heart Association
  4. Uddannelses- og Forskningsministeriet
  5. Human Frontier Science Program
  6. Novo Nordisk
  7. Hoslev Foundation
  8. Aase and Einer Danielsen Foundation
  9. Lundbeckfonden
  10. Gangstedfonden
  11. National Institutes of Health
  12. Lustgarten Foundation
  13. Cancer Research Institute
  14. Claudia Adams Barr Program for Innovative Cancer Research

向作者/读者索取更多资源

Human cytomegalovirus has hijacked and evolved a human G-protein-coupled receptor into US28, which functions as a promiscuous chemokine 'sink' to facilitate evasion of host immune responses. To probe the molecular basis of US28's unique ligand cross-reactivity, we deep sequenced CX3CL1 chemokine libraries selected on 'molecular casts' of the US28 active-state and find that US28 can engage thousands of distinct chemokine sequences, many of which elicit diverse signaling outcomes. The structure of a G-protein-biased CX3CL1-variant in complex with US28 revealed an entirely unique chemokine amino terminal peptide conformation and remodeled constellation of receptor-ligand interactions. Receptor signaling, however, is remarkably robust to mutational disruption of these interactions. Thus, US28 accommodates and functionally discriminates amongst highly degenerate chemokine sequences by sensing the steric bulk of the ligands, which distort both receptor extracellular loops and the walls of the ligand binding pocket to varying degrees, rather than requiring sequence-specific bonding chemistries for recognition and signaling.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据